基于间接超响应性测试的儿童喘治疗:随机对照试验
Janusz Ciółkowski1, Paweł Hydzik2, Marta Rachel3
1Allergology Outpatient Clinic, The Regional Public Hospital in Lesko, Lesko, Poland.
Pediatric pulmonology
|June 21, 2023
概括
使用高血压盐水的间接呼吸道高反应性 (AHR) 测试有助于减少儿童轻度喘恶化. 这种简单的测试有助于有效监测喘治疗.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏和免疫学 过敏和免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 儿童喘管理需要有效的监测工具.
- 评估气道过敏反应 (AHR) 对于控制喘至关重要.
- 吸入性皮质类固醇 (ICS) 是慢性喘的主要治疗方法.
研究的目的:
- 为了评估间接的AHR测试与高血压盐水的实用性.
- 为了确定这项测试是否可以指导ICS剂量,以最佳控制儿童的喘.
- 为了比较AHR指导的管理与基于症状的监测.
主要方法:
- 104名患有轻度至中度无氧喘的儿童 (7-15岁) 参与了这项研究.
- 患者被随机分配到症状监测或AHR引导治疗组.
- 控制喘,精神测量,排气的氧化和血液中异氨基的评价持续了一年.
主要成果:
- 以AHR为指导的组显著减少了轻度恶化 (每名患者0.83对1.67).
- 临床控制,炎症标志物和肺功能改善在各组之间是相似的.
- 血中原氨基酸基线与AHR和恶化风险相关.
结论:
- 间接的AHR测试减少了儿童喘中轻度恶化.
- 高压盐水AHR测试是一种实用,具有成本效益的监测工具.
- 这种方法补充了对儿童轻度至中度喘的症状监测.
相关概念视频
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management
461
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
461
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255


